UPELIOR
DEAD

Serial Number

78461604

Owner

Novartis AG

Attorney

Steven H. Hartman

Filing Date

Aug 4, 2004

Add to watchlist:

No watchlists yet
View on USPTO

UPELIOR Trademark

Serial Number: 78461604 • Registration: 2995324

UPELIOR is a trademark filed by Novartis AG on August 4, 2004. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

August 4, 2004

Registration Date

September 13, 2005

Published for Opposition

June 21, 2005

Cancellation Date

October 12, 2012

Goods & Services

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals

Filing History

NOTICE OF SUIT
Jun 3, 2026 NOSU
NOTICE OF SUIT
Jun 2, 2026 NOSU
CANCELLED SEC. 8 (6-YR)
Oct 12, 2012 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 19, 2009 TCCA
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2005 R.PR
PUBLISHED FOR OPPOSITION
Jun 21, 2005 PUBO
NOTICE OF PUBLICATION
Jun 1, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 10, 2005 PREV
ASSIGNED TO LIE
Mar 7, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
Mar 1, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2005 CNEA
PRIORITY ACTION E-MAILED
Feb 25, 2005 GPRA
PRIORITY ACTION WRITTEN
Feb 25, 2005 CPRA
ASSIGNED TO EXAMINER
Feb 24, 2005 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 19, 2004 TCCA
PAPER RECEIVED
Dec 6, 2004 MAIL
NEW APPLICATION ENTERED
Aug 12, 2004 NWAP